PI3K-IN-1

PI3K-IN-1 (Voxtalisib Analogue) is a potent small molecule inhibitor primarily targeting the p110γ isoform of PI3K and mTOR, with additional activity against DNA-PK. This dual inhibitor is utilized in biochemical and cellular research to investigate oncogenic signaling pathways, including in cancer models both in vitro and in vivo.

Product Specifications

CAS Number

1349796-36-6

Product Name Alternative

PI3Kγ, PI3Kβ, PI3Kδ, PI3Kα, PI3K, PI3K IN 1, PI3KIN1, PI-3K-IN-1, PI3K-IN-1, XL 765, XL-147 derivative 1, XL765, XL-765, thyroid, SAR245409, SAR-245409, SAR 245409, Voxtalisib Analogue, DNA-PK, DNAPK, fibrosis, extraocular, ophthalmopathy

Field of Research

Molecular Biology, Signal Transduction

Purity

97.03% (May vary between batches)

Solubility

DMSO:1 mg/mL (1.67 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (1.67 mM) ; Ethanol:< 1 mg/mL (insoluble or slightly soluble)